The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at ...

Enphase Energy rise after posting better than expected Q4 adjusted earnings, helped by continued gross margin expansion, and ...

Corp released its operations update for January. “With infrastructure upgrades for our initial fleet upgrade near completion, we ...

Uber (NYSE:UBER) is set to announce fourth quarter results on Wednesday, and investors will look at the ride-hailing platform’s gross bookings as well as its future plans for autonomous vehicles (AVs) ...

Alpha Omega Wealth Management LLC cut its holdings in Broadcom Inc. (NASDAQ:AVGO – Free Report) by 4.8% during the fourth ...

We recently published a list of 10 High Growth Financial Stocks To Invest In. In this article, we are going to take a look at ...

"Main Event" Jey Uso is living up to his nickname. The decorated tag team champion was far from the favorite heading into the ...

Q4 2024 Management View CEO Chad Abraham highlighted that Q4 2024 was the company’s strongest quarter of the year, generating adjusted net revenues of $499 million and adjusted EPS of $4.80. He noted ...

The outlook for food producers who rely on cocoa is more challenging in FY25 as unforeseen weather deterioration in West ...